688366 昊海生科
2026/06 - 中期
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入1,179,123-9.60%2,472,9982,697,6582,654,0392,130,276
减:营业总成本1,062,1230.19%2,136,2742,243,9492,187,7431,864,420
    其中:营业成本407,2334.65%738,762812,626782,849660,761
               财务费用(12,729)-58.79%(60,671)(48,703)(62,217)(74,097)
               资产减值损失(20,466)38.14%(198,518)(32,238)(6,741)(54,239)
公允价值变动收益93946.46%31,06225,9152,296(7,784)
投资收益(328)1,042.98%4,5421,0021,1425,808
    其中:对联营企业和合营企业的投资收益(328)432.68%109864563,505
营业利润132,949-43.73%220,210494,761507,413234,586
利润总额132,584-43.73%239,245466,145508,261235,727
减:所得税费用22,063-35.04%30,92489,90295,99145,395
净利润110,521-45.20%208,321376,243412,269190,332
减:非控股权益(2,107)-77.58%(42,687)(44,204)(3,852)9,862
股东净利润112,628-46.64%251,009420,447416,121180,470

市场价值指针
每股收益 (元) *0.490-46.15%1.0801.8001.7501.040
每股派息 (元) *0.250-37.50%1.0001.0001.0000.400
每股净资产 (元) *23.174-3.70%23.51623.90832.94931.670
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容